Home > Healthcare > Medical Devices > Diagnostic Devices > Coronary Heart Disease Diagnostic Imaging Devices Market

Coronary Heart Disease Diagnostic Imaging Devices Market Size

  • Report ID: GMI11128
  • Published Date: Aug 2024
  • Report Format: PDF

Coronary Heart Disease Diagnostic Imaging Devices Market Size

Coronary Heart Disease Diagnostic Imaging Devices Market size was valued at around USD 1.8 billion in 2023 and is estimated to grow at 6.6% CAGR from 2024 to 2032. Coronary heart disease diagnostic imaging devices are medical tools used to visualize and assess the condition of the coronary arteries and the heart. These devices help detect blockages, abnormalities, and other issues that can lead to coronary heart disease (CHD).

 

The increasing prevalence of coronary heart disease is a significant catalyst for market growth. For instance, according to the World Health Organization (WHO), cardiovascular diseases are the leading cause of death globally, taking an estimated 17.9 million lives each year. More than four out of five cardiovascular disease deaths are due to heart attacks and strokes, and one-third of these deaths occur primarily in people under 70 years of age. Thus, this increasing prevalence of coronary heart disease underscores the heightened need for superior treatment options, directly fueling demand in the market.
 

Furthermore, increased awareness about the risks and symptoms of coronary heart disease is leading to more proactive health check-ups and early diagnosis. Early detection is crucial in managing CHD, accelerating the demand for diagnostic imaging devices.
 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Coronary heart disease diagnostic imaging devices industry size was valued at around USD 1.8 billion in 2023 and is estimated to record a 6.6% CAGR from 2024 to 2032, due to increasing prevalence of coronary heart disease.

The computed tomography segment of market is predicted to reach USD 443.8 million by 2032, as CT scans offer high-resolution imaging that is crucial for visualizing the coronary arteries and detecting blockages or narrowing with major detail.

The coronary heart disease diagnostic imaging devices market value in the U.S. is projected to reach USD 1.3 billion by 2032, as coronary heart disease remains a leading cause of death in the U.S. due to aging, poor diet, lack of physical activity, and smoking.

CHISON Medical Technologies Co., Ltd., Esaote SPA, FUJIFILM Holdings Corporation, GE HealthCare Technologies Inc., Koninklijke Philips N.V., Neusoft Corporation, Samsung Electronics Co., Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., and Shimadzu Corporation among others.

Coronary Heart Disease Diagnostic Imaging Devices Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 13
  • Tables & Figures: 231
  • Countries covered: 23
  • Pages: 140
 Download Free Sample